Pricing
Login
Home
Charts
Search
Watchlist
Products

Onyx Biotec Ltd

ONYX
₹39.45+4.92%20 Nov 2026
Reports
Pharma CRAMS

Onyx Biotec Ltd

ONYX
₹39.45
+4.92%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹72Cr
Close
Close Price
₹39.45
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
43.83
PS
Price To Sales
0.91
Revenue
Revenue
₹78Cr
Rev Gr TTM
Revenue Growth TTM
17.92%
PAT Gr TTM
PAT Growth TTM
52.34%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
24303032353543
Growth YoY
Revenue Growth YoY%
26.26.514.79.725.5
Expenses
ExpensesCr
20252427343241
Operating Profit
Operating ProfitCr
3565123
OPM
OPM%
14.316.518.914.62.87.06.6
Other Income
Other IncomeCr
0010000
Interest Expense
Interest ExpenseCr
1111111
Depreciation
DepreciationCr
1122211
PBT
PBTCr
3454123
Tax
TaxCr
0011001
PAT
PATCr
2232-111
Growth YoY
PAT Growth YoY%
86.9-3.0-130.1-65.0204.4
NPM
NPM%
6.76.89.96.2-2.62.02.2
EPS
EPS₹
1.41.72.21.3-0.50.40.5
QuarterSep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026Sep 2026
Revenue
RevenueCr
24303032353543
Growth YoY
Revenue Growth YoY%
26.26.514.79.725.5
Expenses
ExpensesCr
20252427343241
Operating Profit
Operating ProfitCr
3565123
OPM
OPM%
14.316.518.914.62.87.06.6
Other Income
Other IncomeCr
0010000
Interest Expense
Interest ExpenseCr
1111111
Depreciation
DepreciationCr
1122211
PBT
PBTCr
3454123
Tax
TaxCr
0011001
PAT
PATCr
2232-111
Growth YoY
PAT Growth YoY%
86.9-3.0-130.1-65.0204.4
NPM
NPM%
6.76.89.96.2-2.62.02.2
EPS
EPS₹
1.41.72.21.3-0.50.40.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
453954626978
Growth
Revenue Growth%
-12.036.115.312.117.9
Expenses
ExpensesCr
393545526673
Operating Profit
Operating ProfitCr
6481035
OPM
OPM%
12.611.315.516.74.96.8
Other Income
Other IncomeCr
000101
Interest Expense
Interest ExpenseCr
112211
Depreciation
DepreciationCr
112333
PBT
PBTCr
434605
Tax
TaxCr
011201
PAT
PATCr
324502
Growth
PAT Growth%
-45.097.036.3-104.352.3
NPM
NPM%
7.54.76.88.0-0.32.1
EPS
EPS₹
2.81.63.03.3-0.10.9
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
453954626978
Growth
Revenue Growth%
-12.036.115.312.117.9
Expenses
ExpensesCr
393545526673
Operating Profit
Operating ProfitCr
6481035
OPM
OPM%
12.611.315.516.74.96.8
Other Income
Other IncomeCr
000101
Interest Expense
Interest ExpenseCr
112211
Depreciation
DepreciationCr
112333
PBT
PBTCr
434605
Tax
TaxCr
011201
PAT
PATCr
324502
Growth
PAT Growth%
-45.097.036.3-104.352.3
NPM
NPM%
7.54.76.88.0-0.32.1
EPS
EPS₹
2.81.63.03.3-0.10.9
Sales CAGR
1 Year12%
3 Years21%
5 Years-
TTM-
EBITDA CAGR
1 Year-67%
3 Years-9%
5 Years-
TTM-
Avg. ROCE
1 Year1%
3 Years8%
5 Years9%
TTM9%
CFO / EBITDA
1 Year-44%
3 Years7%
5 Years12%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
6613181818
Reserves
ReservesCr
101212373738
Current Liabilities
Current LiabilitiesCr
1020232633
Non Current Liabilities
Non Current LiabilitiesCr
102026107
Total Liabilities
Total LiabilitiesCr
375974919593
Current Assets
Current AssetsCr
1415304951
Non Current Assets
Non Current AssetsCr
2244454244
Total Assets
Total AssetsCr
375974919593
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
6613181818
Reserves
ReservesCr
101212373738
Current Liabilities
Current LiabilitiesCr
1020232633
Non Current Liabilities
Non Current LiabilitiesCr
102026107
Total Liabilities
Total LiabilitiesCr
375974919593
Current Assets
Current AssetsCr
1415304951
Non Current Assets
Non Current AssetsCr
2244454244
Total Assets
Total AssetsCr
375974919593

Cash Flow

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0221-1
Investing Cash Flow
Investing Cash FlowCr
-6-23-31-5
Financing Cash Flow
Financing Cash FlowCr
516352
Net Cash Flow
Net Cash FlowCr
0-417-5
Free Cash Flow
Free Cash FlowCr
-5-21-22-6
CFO To PAT
CFO To PAT%
14.5106.041.728.6696.9
CFO To EBITDA
CFO To EBITDA%
8.643.818.213.7-44.0
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
0221-1
Investing Cash Flow
Investing Cash FlowCr
-6-23-31-5
Financing Cash Flow
Financing Cash FlowCr
516352
Net Cash Flow
Net Cash FlowCr
0-417-5
Free Cash Flow
Free Cash FlowCr
-5-21-22-6
CFO To PAT
CFO To PAT%
14.5106.041.728.6696.9
CFO To EBITDA
CFO To EBITDA%
8.643.818.213.7-44.0

Ratios

Standalone
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1056272
Price To Earnings
Price To Earnings
21.343.8
Price To Sales
Price To Sales
1.70.90.9
Price To Book
Price To Book
1.91.11.3
EV To EBITDA
EV To EBITDA
10.521.415.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.543.731.435.124.324.3
OPM
OPM%
12.611.315.516.74.96.8
NPM
NPM%
7.54.76.88.0-0.32.1
ROCE
ROCE%
15.16.511.812.41.18.8
ROE
ROE%
20.510.114.48.9-0.42.9
ROA
ROA%
9.13.14.95.4-0.21.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
1056272
Price To Earnings
Price To Earnings
21.343.8
Price To Sales
Price To Sales
1.70.90.9
Price To Book
Price To Book
1.91.11.3
EV To EBITDA
EV To EBITDA
10.521.415.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
37.543.731.435.124.324.3
OPM
OPM%
12.611.315.516.74.96.8
NPM
NPM%
7.54.76.88.0-0.32.1
ROCE
ROCE%
15.16.511.812.41.18.8
ROE
ROE%
20.510.114.48.9-0.42.9
ROA
ROA%
9.13.14.95.4-0.21.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr230149128123908072
Close PriceClose₹207.00135.00158.0057.0868.5152.7539.45
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.2443.83
Price To SalesPS2.281.091.834.580.931.230.91
RevenueRevenueCr1011377027976578
Revenue Growth TTMRev Gr TTM%22.3%54.7%-1.4%114.4%17.9%
PAT Growth TTMPAT Gr TTM%44.5%-3.4%51.4%410.3%52.3%
Market CapitalizationMkt CapCr230149128123908072
Close PriceClose₹207.00135.00158.0057.0868.5152.7539.45
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE17.5417.2617.3429.6626.2443.83
Price To SalesPS2.281.091.834.580.931.230.91
RevenueRevenueCr1011377027976578
Revenue Growth TTMRev Gr TTM%22.3%54.7%-1.4%114.4%17.9%
PAT Growth TTMPAT Gr TTM%44.5%-3.4%51.4%410.3%52.3%
Annual Reports
FY2025
Quarterly Reports
FY2026
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Mar 26
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Load More
Interviews